论文部分内容阅读
目的 :观察吉西他滨 (健择 )联合顺铂 (GP方案 )对晚期非小细胞肺癌的疗效。方法 :自 1999年 6月～ 2 0 0 1年11月 ,对 2 6例晚期非小细胞肺癌采用 2 1天GP方案治疗。结果 :2 6例病例中 ,无CR ,PR 11例 ,SD 12例 ,PD 3例 ,总有效率CR +PR为 4 2 3% (11/ 2 6 )。中位生存期 (MST)为 9 3个月。Ⅲ～Ⅳ度白细胞下降占 2 3 1% (6 / 2 6 )。结论 :治疗晚期非小细胞肺癌 ,吉西他滨联合顺铂 2 1天方案是有效、经济和安全的
Objective: To observe the effect of gemcitabine combined with cisplatin on advanced non-small cell lung cancer. Methods: Twenty-six patients with advanced non-small cell lung cancer were treated with 21 day GP regimen from June 1999 to November 2001. Results: There were no CR, PR in 11 cases, SD in 12 cases and PD in 3 of 26 cases. The total effective rate of CR + PR was 42.3% (11/26). The median survival time (MST) was 93 months. Ⅲ ~ Ⅳ leukopenia accounted for 2 3 1% (6/2 6). CONCLUSIONS: The 1-day program for the treatment of advanced non-small cell lung cancer and gemcitabine in combination with cisplatin is effective, economical and safe